(R)-1-[(Sp)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine
CAS: 158923-11-6
Ref. 3D-IGA92311
50mg | 255.00 € | ||
500mg | 1,017.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Product Information
Name:
(R)-1-[(Sp)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine
Synonyms:
- (2R)-1-[(1R)-1-[Bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)ferrocene
- (R)-(-)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyl-di-tert-butylphosphine
- (R)-1-[(S)-2-(Dicyclohexylphosphino)Ferrocenyl]Ethyldi-Tert-Butylphosphine
- (R)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyli-tert-butylphosphine
- (R,R)-1-[1-(Di-Tert-Butylphosphino)Ethyl]-2-(Dicyclohexylphosphino)Ferrocene
- (R,R)-1-[1-(Di-Tert-Butylphosphino)Ethyl]-2-(Dicyclohexylphosphino)Ferrocene (Acc To Cas)
- 1,2,3,4,5-cyclopentanepentayl, compd. with 1-[(1S)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)-1,2,3,4,5-cyclopentanepentayl, iron salt (1:1:1)
- CyPFt-Bu
- Ferrocene, 1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)-, (2R)-
- Ferrocene, 1-[1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)-, [R-(R*,R*)]-
- See more synonyms
- Josiphos Sl-J009-1
- Sl-J009-1
Description:
Versatile small molecule scaffold
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
554.55 g/mol
Formula:
C27H47P2·C5H5·Fe
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-IGA92311 (R)-1-[(Sp)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.